GYRE: the cash flow

MyFinsight

For the year ending 2025-12-31, GYRE had $25,257K increase in cash & cash equivalents over the period. -$190K in free cash flow.

Cash Flow	2025-12-31
Acquisition of intangible assets	733
Purchase of certificates of deposit	14,010
Purchases of property and equipment	1,190
Proceeds from sale of equipment	30
Maturity of certificates of deposit	15,429
Net cash used in investing activities	-474
Net cash provided by financing activities	24,378
Effect of exchange rate changes on cash and cash equivalents	343
Net income from operations	9,880
Stock-based compensation	7,157
Depreciation and amortization	2,481
Noncash lease expense	777
Amortization of land use rights	39
Deferred income taxes, net	-1,109
Bad debt expense and other non-cash items	-63
Accrued interest on bank deposit	-28
Change in fair value of receivables from gcbp	39
Change in fair value of derivative liabilities	39
Equity loss of unconsolidated affiliates	-77
Notes receivable	1,147
Accounts receivable	10,806
Inventories	3,631
Prepaid and other assets	206
Income tax payable	44
Accounts payable	13
Other noncurrent liabilities	-47
Due to related parties	-1
Accrued expenses and other liabilities	946
Operating lease liabilities	-744
Net proceeds from cvr liability settlement	25
Loss on disposal of property and equipment	-4
Change in fair value of warrant liability	-2,707
Net Cash Provided By Used In Operating Activities	1,000
Net increase (decrease) in cash and cash equivalents	25,257
Cash and cash equivalents at beginning of the period	11,813
Cash and cash equivalents at end of period	37,070

Unit: Thousand (K) dollars (except for numbers of shares and EPS).